Mmimetika Biosciences ApS

Mmimetika Biosciences ApS is a Danish biotechnology company that develops lactate-ketone (LaKe) ester dietary supplements designed to mimic the metabolic effects of intense exercise and fasting. Born from over 40 years of research at Aarhus University, the company created a novel, single-molecule ester that converts upon ingestion into both lactate and beta-hydroxybutyrate (BHB). This dual-metabolite approach distinguishes their product from conventional ketone supplements, allowing it to activate specific cellular pathways associated with metabolic stress and energy production without the need for excessive salt intake. The company utilizes a scientifically grounded approach to support metabolic health and cellular signaling.

The organization is focused on commercializing its technology for various health applications, including recovery, metabolic control, cognitive health, and cardiovascular support. Mmimetika has transitioned from clinical validation toward commercial scale, pursuing regulatory pathways such as U.S. GRAS compliance and EFSA Novel Food applications. By providing a non-medicinal supplement that emulates physiological responses to fasting and physical activity, the company aims to offer practical solutions for weight management, blood sugar regulation, and general wellness. Mmimetika is backed by scientific founders and strategic investors and is led by an experienced leadership team dedicated to global commercialization.